Protagonist Therapeutics, Inc. has grown revenue 20% a year over three years and 60% a year over five. Revenue growth, 3-year annual rate: +20% (Biotechnology median +21%). Revenue growth, 5-year rate: +60%, growth has slowed since the five-year average. Years of annual history on file: 12, FY2014 to FY2025, as filed.

PTGXProtagonist Therapeutics, Inc.

HealthcareUSD

$151.50

$51.0752 weeks$158.64

Is it growing?

Is PTGX growing?

Protagonist Therapeutics, Inc. has grown revenue 20% a year over three years and 60% a year over five.

+20%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +60%
Revenue growth, 5-year rate · +20% over three · growth has slowed since the five-year average
Years of annual history on file: 12
Years of annual history on file · FY2014 to FY2025, as filed

Details›